In Nebraska, will the 3rd time be the charm for medical cannabis?
Medical cannabis activists in Nebraska have officially launched their third petition drive, aiming to collect enough signatures to put the legalization of medical cannabis before voters on the general election vote in November 2024.
The Nebraskans for Medical Marijuana will be collecting signatures for two bills:
- The Medical Cannabis Regulation Act, which would create the Nebraska Medical Cannabis Commission to regulate medical cannabis businesses in the state
- The Patient Protection Act (Patient Protection Act) that would ensure that consumers and their caregivers do not suffer legal consequences when using medical cannabis recommended by a healthcare provider
Both petitions require 87,000 valid signatures from registered voters.
Signatures must come from at least 5% of registered voters representing at least 38 of Nebraska's 93 counties. Visit group failed to achieve this by 2022.
On his first attempt, Nebraskans for Medical Marijuana collected enough signatures to put the question to the voters on the 2020 ballot, but the State Supreme Court ruled that the measure was unconstitutional.
Campaign manager Crista Eggers said the group would keep trying.
«There was never any question that we wouldn't come back a third time,» Crista Eggers said in a statement. «This is not an issue we can give up on; it's people's lives we're fighting for.»
-
Business2 weeks ago
The legal cannabis market in New York exceeds 4 billion $ in revenue
-
Cannabis in France3 weeks ago
Which countries legalized medical cannabis before France?
-
Business3 weeks ago
South Korea is preparing to begin local production of medical cannabis to meet rising demand
-
Cannabis in Thailand3 weeks ago
From the boom in dispensaries to a purely medical approach: Thailand is revising its cannabis policy
-
Cannabis and driving3 weeks ago
Medical Cannabis and Driving: New South Wales Ends Automatic Penalties for THC
-
Cannabis in Argentina4 weeks ago
Argentina Opens Its Market to Hemp Flowers Containing 1% of THC
-
Autism3 weeks ago
Autism and Cannabis: Results from the First Placebo-Controlled Trial of NTI164
-
Cannabis in France2 weeks ago
France’s Drug Policy Chief Defends Cannabis Prohibition... and Runs Into the Facts


You must be logged in to post a comment Login